Beacon was founded in 2016 by an experienced drug discovery team exploiting modern advances in the science of G-Protein Coupled Receptors (GPCRs). We are comprised of a group of dedicated scientists who have worked together for more than fifteen years and we are world leaders in all facets of GPCR-focused drug discovery. As a GPCR drug discovery incubator, Beacon has leveraged its research portfolio and expertise to secure pa...
Beacon was founded in 2016 by an experienced drug discovery team exploiting modern advances in the science of G-Protein Coupled Receptors (GPCRs). We are comprised of a group of dedicated scientists who have worked together for more than fifteen years and we are world leaders in all facets of GPCR-focused drug discovery. As a GPCR drug discovery incubator, Beacon has leveraged its research portfolio and expertise to secure partnerships with both small biotech start-ups and large pharma partners. These partnerships represent validation of our approach. We believe that no other company can boast the experience or expertise of Beacon.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.